cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Humanigen Inc
15 own
16 watching
Current Price
$0.22
$-0.01
(-2.46%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
26.44M
52-Week High
52-Week High
4.105
52-Week Low
52-Week Low
0.0924
Average Volume
Average Volume
2.4M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization26.44M
icon52-Week High4.105
icon52-Week Low0.0924
iconAverage Volume2.4M
iconDividend Yield--
iconP/E Ratio--
What does the Humanigen Inc do?
Humanigen, Inc., a clinical-stage biopharmaceutical company, focuses on preventing and treating an immune hyper-response called ‘cytokine storm . Lenzilumab is an antibody that binds to and neutralizes granulocyte-macrophage colony-stimulating factor (GM-CSF). The company is developing lenzilumab as a treatment for cytokine storm associated with COVID-19 for which it has completed a Phase 3 study and is the focus of a Phase 2/3 study sponsored by the NIH. It is also developing lenzilumab, which is also being studied in conjunction with CD19-targeted CAR-T cell therapies, as well as exploring the effectiveness of lenzilumab in other inflammatory conditions, such as acute Graft versus Host Disease in patients undergoing allogeneic hematopoietic stem cell transplantation and in eosinophilic asthma, and rheumatoid arthritis. In addition, the company focuses on studying lenzilumab for patients with chronic myelomonocytic leukemia exhibiting RAS pathway mutations. Its pipeline also includes two other Humaneered monoclonal antibodies, ifabotuzumab, which binds to EphA3, and HGEN005, which targets EMR1. Ifabotuzumab has been evaluated in a Phase 1 study of glioblastoma multiforme that showed tumor specific targeting of all known tumor sites with no normal tissue uptake. HGEN005 is being explored as a treatment for a range of eosinophilic diseases, including eosinophilic leukemia as an optimized naked antibody and as the backbone for a novel CAR-T construct. Humanigen, Inc. was incorporated in 2000 and is headquartered in Short Hills, New Jersey.
Read More
How much money does Humanigen Inc make?
News & Events about Humanigen Inc.
PR Newswire
1month ago
Thinking about buying stock in Mullen Automotive, Humanigen, Vyant Bio, IQIYI, or Lucira Health? Thinking about buying stock in Mullen Automotive, Humanigen, Vyant Bio, IQIYI, or Lucira Health? PR Newswire NEW YORK, Jan. 5, 2023 NEW YORK, Jan. 5, 2023 /PRNewswire/ -- InvestorsObserverissues...
Business Wire
3 months ago
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Humanigen, Inc. (Humanigen or the Company) (NASDAQ: HGEN) and certain of its officers on behalf of all persons and entities that purchased, or otherwise acquired...
Globe Newswire
3 months ago
NEW YORK, Oct. 25, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Humanigen, Inc. (NASDAQ: HGEN) between May 16, 2020 and July 12, 2022, both dates inclusive (the Class Period) of the important October 25, 2022 lead plaintiff ...
Globe Newswire
3 months ago
NEW YORK, Oct. 24, 2022 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links belowor you may contact ...
PR Newswire
3 months ago
HGEN DEADLINE TOMORROW: ROSEN, SKILLED INVESTOR COUNSEL Encourages Humanigen, Inc. Investors With Losses Exceeding $100K to Secure Counsel Before Important Tuesday Deadline in Securities Class Action - HGEN HGEN DEADLINE TOMORROW: ROSEN, SKILLED INVESTOR COUNSEL Encourages Humanigen, Inc. Investors...
Frequently Asked Questions
Frequently Asked Questions
What is Humanigen Inc share price today?
plus_minus_icon
Can Indians buy Humanigen Inc shares?
plus_minus_icon
How can I buy Humanigen Inc shares from India?
plus_minus_icon
Can Fractional shares of Humanigen Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Humanigen Inc stocks?
plus_minus_icon
What is today’s traded volume of Humanigen Inc?
plus_minus_icon
What is today’s market capitalisation of Humanigen Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Humanigen Inc?
plus_minus_icon
What percentage is Humanigen Inc down from its 52-Week High?
plus_minus_icon
What percentage is Humanigen Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0.22
$-0.01
(-2.46%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00